Navigation Links
Cardium Reports on Third Quarter 2008 Financial Results and Revised Business Strategies for Operating Units
Date:11/10/2008

), CoolBlue(TM). Accutrol(R), Temperature Control Element(R) and
TCE(R) and UroCool(TM) are trademarks of InnerCool Therapies, Inc.

Selected Consolidated Operational Results (Unaudited)

Three Months Ended Nine Months Ended

September 30,

September 30,

2008 2007 2008 2007

Statements of Operations

Data:

Total Revenues $585,421 $364,330 $1,858,264 $903,133

Cost of goods sold (514,243) (318,934) (1,199,193) (823,676)

Gross profit 71,178 45,396 659,071 79,457

Research and

development 2,947,997 3,243,008 10,289,883 9,901,087

Selling, general and

administrative 2,886,089 2,838,949 8,968,214 8,356,498

Amortization -

Intangibles 197,414 178,156 592,242 592,242

Loss from

operations (5,960,322) (6,214,717) (19,191,268) (18,770,370)

Interest, Net (191,193) 146,748 (328,837) 461,371

Net loss (6,151,515) (6,067,969) (19,520,105) (18,308,999)

Net loss per common

share - basic and

diluted

(0.13) (0.15) (0.44) (0.47)

Weighted average

shares

outstanding-

basic and

diluted 46,603,700 40,928,219 44,322,663 38,759,118

Selected Consolidated

Balance Sheet Data: September 30, December 31,

2008 2007 (audited)

Cash and cash

equivalents $126,575 $7,722,816

Accounts receivable,

net 119,849 565,613

Inventory 1,818,021 1,037,164

Prepaid expenses and

other current assets 414,933 522,067

Property and equipment,


'/>"/>

SOURCE Cardium Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Cardium Announces FDA 510(K) Clearance of InnerCools RapidBlue(TM) Endovascular System
2. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
3. Cardium Announces InnerCools New RapidBlue(TM) System Obtains CE Mark for Commercial Sale in Europe and UL certification
4. Cardium Announces Follow-On Direct Investment by Institutional Investor
5. Cardium Selected for Inclusion in Russell Microcap Index
6. Cardiums InnerCool Therapies Unit Announces Italian Commercialization Agreement for Portfolio of Temperature Modulation Systems
7. Cardium Launches New AWARE Clinical Study Website
8. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
9. Cardium Therapeutics Announces Annual Meeting of Stockholders to be Held June 5, 2008
10. Cardium Reports on First Quarter 2008 Highlights and Financial Results
11. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)... , QUINCY, Mass., Nov. 6 Myri..., biotech developer and manufacturer of renewable...s preferred technology provider Uhde GmbH, one of ...ly "Uhde"), announced an alliance for the engineer...nt,s biobased Succinic Acid plants based on renewa...
(Date:11/6/2009)... , SAN MATEO, Calif., Nov. 6 /PRNewswire-Firs..., Completed transfer of Qutenza(TM) E.U. Market... Made significant progress in commercial readiness...P Sales; Senior Director, Marketing; and Director,...win to board as director and Audit Committee chair...
(Date:11/6/2009)... , CALGARY, Nov. 6 /PRNewswire-FirstCall/ - O...colytics" or the "Company") today announced update...LYSIN(R) in patients with sarcomas metastatic to t...l Connective Tissue Oncology Society Meeting held ... The poster presentation, entitled "A Phase II Stu...
(Date:11/6/2009)... , The agenda for Arrowhe... Conference, which is set to take place on Februar... At this three day conference we will highlight ke...st speakers to share their experiences. , ...6, 2009 -- The agenda for Arrowhead’s 2010 ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
...e topic of economic crisis comes up, an area that ...th institutions such as the University of Wiscons...llege churning out talented graduates every year ...area seems to be a relatively stable environment t...rs such as the gradual switch of manufacturing to ...
...ment in a series examining successful dot-coms in ...hen the infamous dot-com crash hit in March of 200...urs who thought that they could make it rich with ...sive spending and a downward spiral in the stock m...d to suffer, laying off employees and dropping ou...
... that delivers data at 1.5M bit/sec (and up to 3M ...o be thrilled to get great performance from the fi...e. Until I heard from Samsung,s GS Choi, president...lighted with the data speeds delivered to my home ...adband Internet in the United States is "pitiable,...
Other Biology Technology:A cry for unity for the economy of southeast Wisconsin 2A cry for unity for the economy of southeast Wisconsin 3A cry for unity for the economy of southeast Wisconsin 4Online industry remains music to Broadjams ears 2Online industry remains music to Broadjams ears 3Online industry remains music to Broadjams ears 4Imagine the possibilites if you had very high-speed broadband 2Imagine the possibilites if you had very high-speed broadband 3Imagine the possibilites if you had very high-speed broadband 4
(Date:11/9/2009)..., The brilliance of butterfly wings has inspired ...to deliver innovation in the fields of security, e...r and international technology company QinetiQ hav...new technologies based on groundbreaking physical ...a team of physicists from the University of Exeter...
(Date:11/9/2009)..., A chemical culprit responsible for the rapid, m...ntic Ocean has been found by collaborating scienti...ographic Institution (WHOI). This same chemical m... The team discovered a previously unknown lipid, o...ng and killing Emiliania huxleyi , a phytoplankto...
(Date:11/8/2009)..., WEST LAFAYETTE, Ind. - Researchers at Purdue U...ring damaged nerve fibers in spinal cord injuries ... blood shortly after an accident. , The syntheti...bout 60 nanometers in diameter, or roughly 100 tim..., Researchers have been studying how to deliver ...
Breaking Biology News(10 mins):£3.2m ($5.4 million) research project to capture brilliance of butterfly wings 2Newly discovered fat molecule: An undersea killer with an upside 2Newly discovered fat molecule: An undersea killer with an upside 3Newly discovered fat molecule: An undersea killer with an upside 4Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 1Blood flow metabolism mismatch predicts pancreatic tumor aggressiveness 9697 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 1UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 2UTs Valentin Dragoi gets 241 2 million grant for groundbreaking approach to brain research 9695 3Drug Companies Often Unprepared For REMS Evaluation Expert Warns 55310 1
...tes of Health (NIH) researchers have identified a ... deadliest form of skin cancer. The finding is rep...rt of a systematic genetic analysis of a group of ...ypes of cancer. , The NIH analysis found that on... mutations, in genes that code for matrix metallop...
...a. Based on research that reveals new insight int...ve, researchers at the Mayo Clinic campus in Flori...er from spreading. A cancer that spreads elsewhere...that most often leads to death from the disease. ,...logy , researchers say that a molecule known as pr...
...ings appear to echo the insect worlds portrayed in...he characters live in rigidly conformist societies... and Oxford reached their conclusion by creating a...ooperative groups of animals, known as superorgani...re two scenarios in which a group can act as a uni...
Other Biology News:Skin cancer study uncovers new tumor suppressor gene 2Skin cancer study uncovers new tumor suppressor gene 3Mayo Clinic researchers discover and manipulate molecular interplay that moves cancer cells 2
...a;-1, clone C464.6 GenBank Accession Number : NM_...isolated from membrane fractions of rabbit kidney ....4, 0.15M NaCl containing 0.05% sodium azide Quali... rat brain microsomal preparations Recognizes &alp...
Mouse Anti-Human PSGL-1 Monoclonal Antibody, Unconjugated, Clone 215 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Adenovirus Type 7 hexon C11 Monoclonal Antibody, Unconjugated, Clone 1-N-14 from GeneTex
Mouse Anti-20S proteasome subunits alpha 1 Monoclonal Antibody, Unconjugated, Clone MCP231 from Upstate
Biology Products: